RCM

RA Capital Management Portfolio holdings

AUM $5.94B
This Quarter Return
+13.86%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$5.94B
AUM Growth
+$5.94B
Cap. Flow
-$357M
Cap. Flow %
-6.02%
Top 10 Hldgs %
66.2%
Holding
90
New
5
Increased
9
Reduced
10
Closed
27

Top Buys

1
CDTX icon
Cidara Therapeutics
CDTX
$111M
2
TSHA icon
Taysha Gene Therapies
TSHA
$29.3M
3
RNA icon
Avidity Biosciences
RNA
$27.4M
4
HNGE
Hinge Health, Inc.
HNGE
$15.5M
5
TYRA icon
Tyra Biosciences
TYRA
$14.9M

Top Sells

1
JBIO
Jade Biosciences, Inc. Common Stock
JBIO
$81.2M
2
APGE icon
Apogee Therapeutics
APGE
$58.6M
3
ZLAB icon
Zai Lab
ZLAB
$46.8M
4
DAWN icon
Day One Biopharmaceuticals
DAWN
$45.6M
5
URGN icon
UroGen Pharma
URGN
$35.5M

Sector Composition

1 Healthcare 99.82%
2 Financials 0.13%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
DNTH icon
26
Dianthus Therapeutics
DNTH
$759M
$53.4M 0.9%
2,866,733
– –
RXST icon
27
RxSight
RXST
$370M
$48.1M 0.81%
3,702,967
-40,051
-1% -$521K
TRML icon
28
Tourmaline Bio
TRML
$601M
$40.6M 0.68%
2,538,925
– –
SRRK icon
29
Scholar Rock
SRRK
$3.14B
$40.3M 0.68%
1,136,453
– –
CLYM
30
Climb Bio, Inc. Common Stock
CLYM
$151M
$39M 0.66%
31,419,267
– –
GPCR icon
31
Structure Therapeutics
GPCR
$1.16B
$31.5M 0.53%
1,517,418
– –
SLDB icon
32
Solid Biosciences
SLDB
$427M
$28.3M 0.48%
5,811,323
+1,480,877
+34% +$7.21M
MTSR
33
Metsera, Inc. Common Stock
MTSR
$3.8B
$19.2M 0.32%
675,525
– –
MNPR icon
34
Monopar Therapeutics
MNPR
$211M
$18.3M 0.31%
511,207
– –
NKTX icon
35
Nkarta
NKTX
$151M
$17.9M 0.3%
10,805,129
– –
LRMR icon
36
Larimar Therapeutics
LRMR
$318M
$17.5M 0.29%
6,045,351
– –
ABOS icon
37
Acumen Pharmaceuticals
ABOS
$82.4M
$17.3M 0.29%
14,932,063
– –
ELVN icon
38
Enliven Therapeutics
ELVN
$1.2B
$17M 0.29%
848,986
– –
TVTX icon
39
Travere Therapeutics
TVTX
$1.56B
$17M 0.29%
1,150,000
– –
FDMT icon
40
4D Molecular Therapeutics
FDMT
$287M
$16.9M 0.29%
4,563,211
– –
HNGE
41
Hinge Health, Inc.
HNGE
$4.37B
$15.5M 0.26%
+300,000
New +$15.5M
ARTV
42
Artiva Biotherapeutics, Inc. Common Stock
ARTV
$76.7M
$14.9M 0.25%
9,853,302
– –
PEPG icon
43
PepGen
PEPG
$38M
$11.9M 0.2%
10,689,545
– –
JBIO
44
Jade Biosciences, Inc. Common Stock
JBIO
$258M
$10.6M 0.18%
1,062,326
-8,129,766
-88% -$81.2M
TNGX icon
45
Tango Therapeutics
TNGX
$747M
$10.2M 0.17%
+2,000,000
New +$10.2M
ACRV icon
46
Acrivon Therapeutics
ACRV
$42.2M
$9.93M 0.17%
8,340,508
– –
ELDN icon
47
Eledon Pharmaceuticals
ELDN
$155M
$9.66M 0.16%
3,566,338
– –
RCUS icon
48
Arcus Biosciences
RCUS
$1.13B
$9.25M 0.16%
1,136,364
– –
PCSC
49
Perceptive Capital Solutions Corp Class A Ordinary Shares
PCSC
$117M
$7.97M 0.13%
750,000
– –
OMDA
50
Omada Health, Inc. Common Stock
OMDA
$1.36B
$7.32M 0.12%
+400,000
New +$7.32M
1
2
3 4